Physician profile
David B Auyong
NPI 1316968217
$284,140.44
in general payments reported to CMS, 2019-2025
7 companies · $56K in 2025
The $56K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $10K · 2021: $7,551 · 2022: $56K · 2023: $33K · 2024: $49K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $107K · Consulting Fee: $19K · Travel and Lodging: $8,541 · Food and Beverage: $3,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $107,483.71 |
| Consulting Fee | $19,011.35 |
| Travel and Lodging | $8,541.01 |
| Food and Beverage | $3,028.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $255,519.46 | 2019-2025 | On-Q, On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Fujifilm Sonosite, INC. | $25,363.40 | 2022-2024 | Sonosite Px Ultrasound System, Sonosite Edge |
| Philips North America LLC | $2,765.00 | 2023 | |
| Si-Bone, INC. | $167.73 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $123.28 | 2024 | Exparel, Iovera |
| Eagle Pharmaceuticals, INC. | $100.93 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $100.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Auyong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.